Cargando…

LAPTM4B Allele *2 Is a Marker of Poor Prognosis Following Hepatic Tumor Resection for Hepatocellular Carcinoma

BACKGROUND: Lysosomal protein transmembrane 4 beta (LAPTM4B) is a gene related to hepatocellular carcinoma that has two alleles designated LAPTM4B*1 and LAPTM4B*2. This study aimed to investigate the correlation of LAPTM4B genotype with prognosis and clinicopathologic features in patients who have u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hua, Zhai, Guojun, Ji, Xiaoxu, Xiong, Fuxia, Su, Jing, McNutt, Michael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318008/ https://www.ncbi.nlm.nih.gov/pubmed/22509374 http://dx.doi.org/10.1371/journal.pone.0034984

Ejemplares similares

LAPTM4B Allele *2 Is a Marker of Poor Prognosis for Gallbladder Carcinoma
por: Zhai, Guojun, et al.
Publicado: (2012)

Overexpression of LAPTM4B-35: A Novel Marker of Poor Prognosis of Prostate Cancer
por: Zhang, Hongtuan, et al.
Publicado: (2014)

LAPTM4B Allele *2 Is Associated with Breast Cancer Susceptibility and Prognosis
por: Li, Xiaoyan, et al.
Publicado: (2012)

Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients
por: Li, Sha, et al.
Publicado: (2017)

Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers
por: Cheng, Xiaojing, et al.
Publicado: (2016)

LAPTM4B*2 allele is associated with the development of papillary thyroid carcinoma in Chinese women
por: Meng, Yue, et al.
Publicado: (2017)

Transport of LAPTM5 to lysosomes requires association with the ubiquitin ligase Nedd4, but not LAPTM5 ubiquitination
por: Pak, Youngshil, et al.
Publicado: (2006)

LAPTM4B facilitates tumor growth and induces autophagy in hepatocellular carcinoma
por: Wang, Fei, et al.
Publicado: (2019)

LAPTM5 Plays a Key Role in the Diagnosis and Prognosis of Testicular Germ Cell Tumors
por: Li, Xiunan, et al.
Publicado: (2021)

CHD1L Is a Marker for Poor Prognosis of Hepatocellular Carcinoma after Surgical Resection
por: Hyeon, Jiyeon, et al.
Publicado: (2013)

Expression of Hypoxic Marker Carbonic Anhydrase IX Predicts Poor Prognosis in Resectable Hepatocellular Carcinoma
por: Huang, Wei-Ju, et al.
Publicado: (2015)

LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells
por: Maki, Yuho, et al.
Publicado: (2015)

Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer
por: Kong, Fanming, et al.
Publicado: (2016)

LAPTM4B promotes the progression of nasopharyngeal cancer
por: Su, Qun, et al.
Publicado: (2021)

LAPTM4B-YAP loop feedback amplification enhances the stemness of hepatocellular carcinoma
por: Liao, Jianping, et al.
Publicado: (2023)

LAPTM4B-35, a Cancer-Related Gene, Is Associated with Poor Prognosis in TNM Stages I-III Gastric Cancer Patients
por: Cheng, Xiaojing, et al.
Publicado: (2015)

LAPTM4B Gene Expression and Polymorphism as Diagnostic Markers of Breast Cancer in Egyptian Patients
por: Shaker, Olfat, et al.
Publicado: (2015)

LAPTM5 Restricts HIV-1 Infection in Dendritic Cells and Is Counteracted by Vpr
por: Ouyang, Jiayue, et al.
Publicado: (2022)

Down-regulation of LAPTM5 in human cancer cells
por: Nuylan, Michelle, et al.
Publicado: (2016)

MBD2 as a novel marker associated with poor survival of patients with hepatocellular carcinoma after hepatic resection
por: Liu, Wei, et al.
Publicado: (2016)

Allele Loss and Down-Regulation of Heparanase Gene Are Associated with the Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Guo-Liang, et al.
Publicado: (2012)

LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR
por: Wang, Lu, et al.
Publicado: (2019)

Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection
por: Shen, Shun-Li, et al.
Publicado: (2014)

Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages
por: Zhao, Li, et al.
Publicado: (2021)

Association between LAPTM4B gene polymorphism and susceptibility to and prognosis of diffuse large B-cell lymphoma
por: Ding, Huirong, et al.
Publicado: (2018)

Elevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative Resection
por: Meng, Jun, et al.
Publicado: (2019)

Preoperative inflammatory markers of NLR and PLR as indicators of poor prognosis in resectable HCC
por: Wang, Dong, et al.
Publicado: (2019)

Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection
por: Wang, Jia-Xing, et al.
Publicado: (2014)

TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection
por: Wang, Cheng-Hao, et al.
Publicado: (2015)

LAPTM4B: an oncogene in various solid tumors and its functions
por: Meng, Y, et al.
Publicado: (2016)

LAPTM5–CD40 Crosstalk in Glioblastoma Invasion and Temozolomide Resistance
por: Berberich, Anne, et al.
Publicado: (2020)

Overexpression of C-reactive Protein as a Poor Prognostic Marker of Resectable Hepatocellular Carcinomas
por: Shin, Jin Ho, et al.
Publicado: (2015)

ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection
por: Hwang, Hye Won, et al.
Publicado: (2015)

Long Noncoding RNA HCAL Facilitates the Growth and Metastasis of Hepatocellular Carcinoma by Acting as a ceRNA of LAPTM4B
por: Xie, Cheng-Rong, et al.
Publicado: (2017)

AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity
por: Meng, Yue, et al.
Publicado: (2018)

High RPS11 level in hepatocellular carcinoma associates with poor prognosis after curative resection
por: Zhou, Chenhao, et al.
Publicado: (2020)

LAPTM5 is transactivated by RUNX2 and involved in RANKL trafficking in osteoblastic cells
por: Geng, Yuan-Ming, et al.
Publicado: (2019)

Influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma: a meta-analysis of observational studies
por: Zhou, Yanming, et al.
Publicado: (2011)

Changes in Inflammatory Markers Predict the Prognosis of Resected Hepatocellular Carcinoma with Child–Pugh A
por: Zhou, Jing, et al.
Publicado: (2022)

Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma
por: Ma, Ming-Chun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0sfh3vqb8a7lm01e3gtt28fstp